Stress cardiomyopathy misinterpreted as ST-segment elevation myocardial infarction in a patient with aneurysmal subarachnoid hemorrhage: a case report
References
- 1. WARTENBERG KE, MAYER SA. Medical Complications After Subarachnoid Hemorrhage. Neurosurg Clin N Am. 2010; 21(2):325–38.
- 2. ARONOW WS. Neurogenic stress cardiomyopathy associated with subarachnoid hemorrhage. Future Cardiol. 2015; 11(1):77–87.
- 3. HUANG CC, HUANG CH, KUO HY, CHAN CM, CHEN JH, CHEN WL. The 12-lead electrocardiogram in patients with subarachnoid hemorrhage: Early risk prognostication. Am J Emerg Med. 2012; 30(5):732–6.
- 4. MANSELLA G, JEGER R, BINGISSER R, NICKEL C. The Neurocardiogenic Spectrum in Subarachnoid Hemorrhage: A Case Report and Review of the Literature. Clin Pract Cases Emerg Med. 2017; 1(1):16–21.
- 5. BISO S, WONGRAKPANICH S, AGRAWAL A, YADLAPATI S, KISHLYANSKY M, FIGUEREDO V. A Review of Neurogenic Stunned Myocardium. Cardiovasc Psychiatry Neurol. 2017; 2017.
- 6. BRIGNOLE M, MOYA A, DE LANGE FJ, DEHARO JC, ELLIOTT PM, FANCIULLI A, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018; 39(21):1883–948.
- 7. SUWATCHARANGKOON S, MEYERS E, FALO C, SCHMIDT JM, AGARWAL S, CLAASSEN J, et al. Loss of consciousness at onset of subarachnoid hemorrhage as an important marker of early brain injury. JAMA Neurol. 2016; 73(1):28–35.
- 8. CREMERS CHP, VAN DER BILT IAC, VAN DER SCHAAF IC, VERGOUWEN MDI, DANKBAAR JW, CRAMER MJ, et al. Relationship Between Cardiac Dysfunction and Cerebral Perfusion in Patients with Aneurysmal Subarachnoid Hemorrhage. Neurocrit Care. 2016; 24(2):202–6.
- 9. KERRO A, WOODS T, CHANG JJ. Neurogenic stunned myocardium in subarachnoid hemorrhage. J Crit Care. 2017; 38:27–34.
- 10. GHADRI JR, WITTSTEIN IS, PRASAD A, SHARKEY S, DOTE K, AKASHI YJ, et al. International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology. Eur Heart J. 2018; 39(22):2032–46.
- 11. KRISHNAMOORTHY V, BURKHARD MACKENSEN G, GIBBONS EF, VAVILALA MS. Cardiac dysfunction after neurologic injury what do we know and where are we going? Chest. 2016; 149(5):1325–31.
- 12. TAMIS-HOLLAND JE, JNEID H, REYNOLDS HR, AGEWALL S, BRILAKIS ES, BROWN TM, et al. Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association. Circulation. 2019; 139(18):E891–908.
- 13. KENIGSBERG BB, BARNETT CF, MAI JC, CHANG JJ. Neurogenic Stunned Myocardium in Severe Neurological Injury. Curr Neurol Neurosci Rep. 2019; 19(11).
- 14. ANCONA F, BERTOLDI LF, RUGGIERI F, CERRI M, MAGNONI M, BERETTA L, et al. Takotsubo cardiomyopathy and neurogenic stunned myocardium: Similar albeit different. Eur Heart J. 2016; 37(37):2830–2.
- 15. GUGLIN M, NOVOTOROVA I. Neurogenic Stunned Myocardium and Takotsubo Cardiomyopathy Are the Same Syndrome: A Pooled Analysis. Congest Hear Fail. 2011; 17(3):127–32.
- 16. WYBRANIEC M, MIZIA-STEC K, KRZYCH Ł. Neurocardiogenic injury in subarachnoid hemorrhage: A wide spectrum of catecholamin-mediated brain-heart interactions. Cardiol J. 2014; 21(3):220–8.
- 17. MEDINA DE CHAZAL H, DEL BUONO MG, KEYSER-MARCUS L, MA L, MOELLER FG, BERROCAL D, et al. Stress Cardiomyopathy Diagnosis and Treatment: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018; 72(16):1955–71.
- 18. BULSARA KR, MCGIRT MJ, LIAO L, VILLAVICENCIO AT, BOREL C, ALEXANDER MJ, et al. Use of the peak troponin value to differentiate myocardial infarction from reversible neurogenic left ventricular dysfunction associated with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2003; 98(3):524–8.
- 19. TEMPLIN C, GHADRI JR, DIEKMANN J, NAPP LC, BATAIOSU DR, JAGUSZEWSKI M, et al. Clinical features and outcomes of takotsubo (stress) cardiomyopathy. N Engl J Med. 2015; 373(10):929–38.
- 20. GHADRI JR, CAMMANN VL, JURISIC S, SEIFERT B, NAPP LC, DIEKMANN J, et al. A novel clinical score (InterTAK Diagnostic Score) to differentiate takotsubo syndrome from acute coronary syndrome: results from the International Takotsubo Registry. Eur J Heart Fail. 2017; 19(8):1036–42.
- 21. KWOK CS, KONTOPANTELIS E, MYINT PK, ZAMAN A, BERRY C, KEAVNEY B, et al. Stroke following percutaneous coronary intervention: Type-specific incidence, outcomes and determinants seen by the British Cardiovascular Intervention Society 2007-12. Eur Heart J. 2015; 36(25):1618–28.
- 22. POTTEGÅRD A, RODRÍGUEZ LAG, POULSEN FR, HALLAS J, GAIST D. Antithrombotic drugs and subarachnoid haemorrhage risk: A nationwide case-control study in Denmark. Thromb Haemost. 2015; 114(5):1064–75.
Language: English
Page range: 173 - 177
Submitted on: Mar 16, 2020
Published on: Aug 10, 2020
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2020 Iulian Enache, Răzvan Alexandru Radu, Elena Oana Terecoasă, Bogdan Dorobăţ, Cristina Tiu, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.